Epithelial-Mesenchymal Transition (EMT) Is Not Sufficient for Spontaneous Murine Breast Cancer Metastasis

被引:102
作者
Lou, Yuanmei [1 ]
Preobrazhenska, Olena [1 ]
Keller, Ulrich auf dem [2 ]
Sutcliffe, Margaret [3 ]
Barclay, Lorena [3 ]
McDonald, Paul C. [1 ]
Roskelley, Calvin [4 ]
Overall, Christopher M. [2 ]
Dedhar, Shoukat [1 ,2 ]
机构
[1] British Columbia Canc Res Ctr, Dept Canc Genet, Vancouver, BC V5Z 1L3, Canada
[2] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada
[3] British Columbia Canc Res Ctr, Dept Canc Imaging, Vancouver, BC V5Z 1L3, Canada
[4] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada
关键词
EMT; breast cancer; spontaneous metastasis; invasion; migration; imaging;
D O I
10.1002/dvdy.21658
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Epithelial-mesenchymal transition (EMT) has been linked to metastatic propensity. The 4T1 tumor is a clinically relevant model of spontaneous breast cancer metastasis. Here we characterize 4T1-derived cell lines for EMT, in vitro invasiveness and in vivo metastatic ability. Contrary to expectations, 67NR cells, which form primary tumors but fail to metastasize, express vimentin and N-cadherin, but not E-cadherin. 4T1 cells express E-cadherin and ZO-1, but are migratory, invasive, and metastasize to multiple sites. 66c14 cells form lung metastases and display a mixed phenotype, but are not as migratory or invasive as 67NR cells. These findings demonstrate that the metastatic ability of breast cancer cells does not strictly correlate with genotypic and phenotypic properties of EMT per se, and suggest that other processes may govern metastatic capability. Gene expression analysis of primary tumors did not identify differences in EMT markers, but did reveal candidate genes that may influence metastatic ability. Developmental Dynamics 237:2755-2768, 2008. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:2755 / 2768
页数:14
相关论文
共 50 条
[41]   Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer [J].
Du, Bowen ;
Shim, Joong Sup .
MOLECULES, 2016, 21 (07)
[42]   Epithelial-mesenchymal transition inhibition by metformin reduces melanoma lung metastasis in a murine model [J].
Veloso, Emerson Soares ;
de Carvalho, Barbara Andrade ;
de Souza Silva, Felipe Henrique ;
Ribeiro, Thais Salviana ;
Lima, Bruna Mendes ;
Almeida, Camila Pereira ;
Soares Romao da Silva, Vitor Henrique ;
Rocha, Sara Aparecida ;
de Araujo Campos, Marina Rios ;
Del Puerto, Helen Lima ;
Ferreira, Enio .
SCIENTIFIC REPORTS, 2022, 12 (01)
[43]   Cetyltrimethylammonium bromide inhibits the metastasis of breast cancer to the lungs by inhibiting epithelial-mesenchymal transition [J].
Li, Ning ;
Chen, Yang ;
Yang, Yongjie ;
Lyu, Shuhan ;
Pan, Yue .
BIOCELL, 2022, 46 (06) :1473-1482
[44]   MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis [J].
Fan Yang ;
Xingchun Zhou ;
Xia Miao ;
Tao Zhang ;
Xiaojun Hang ;
Ru Tie ;
Nan Liu ;
Fei Tian ;
Fuli Wang ;
Jianlin Yuan .
Breast Cancer Research and Treatment, 2014, 145 :23-32
[45]   Despicable role of epithelial-mesenchymal transition in breast cancer metastasis: Exhibiting de novo restorative regimens [J].
Famta, Paras ;
Shah, Saurabh ;
Dey, Biswajit ;
Kumar, Kondasingh Charan ;
Bagasariya, Deepkumar ;
Vambhurkar, Ganesh ;
Pandey, Giriraj ;
Sharma, Anamika ;
Srinivasarao, Dadi A. ;
Kumar, Rahul ;
Guru, Santosh Kumar ;
Raghuvanshi, Rajeev Singh ;
Srivastava, Saurabh .
CANCER PATHOGENESIS AND THERAPY, 2025, 3 (01) :30-47
[46]   The crosstalk between metabolic reprogramming and epithelial-mesenchymal transition and their synergistic roles in distant metastasis in breast cancer [J].
Yu, Liyan ;
Chen, Yongni ;
Chen, Yingyu ;
Luo, Kangwei .
MEDICINE, 2024, 103 (24) :e38462
[47]   Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation [J].
Voutsadakis, Ioannis A. .
JOURNAL OF CLINICAL MEDICINE, 2016, 5 (01)
[48]   RGS10 deficiency facilitates distant metastasis by inducing epithelial-mesenchymal transition in breast cancer [J].
Liu, Yang ;
Jiang, Yi ;
Qiu, Peng ;
Ma, Tie ;
Bai, Yang ;
Bu, Jiawen ;
Hu, Yueting ;
Jin, Ming ;
Zhu, Tong ;
Gu, Xi .
ELIFE, 2024, 13
[49]   Molecular drivers of epithelial-mesenchymal transition (EMT) in glioblastoma and impact on therapy resistance [J].
Tian, Yu ;
Li, Juan ;
Cai, Xue ;
Huang, Youcai ;
Wang, Xiaoling ;
Liu, Qinxian ;
Ashrafizadeh, Milad ;
Guo, Yu ;
Zhen, Haining ;
Tu, Yanyang .
PATHOLOGY RESEARCH AND PRACTICE, 2025, 272
[50]   The mechanism of the contribution of ICAM-1 to epithelial-mesenchymal transition (EMT) in bladder cancer [J].
Zarzycka, Marta ;
Kotula-Balak, Malgorzata ;
Gil, Dorota .
HUMAN CELL, 2024, 37 (03) :801-816